Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FEMPB
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,975
Award facts
- Contract value 100% obligated
- $16,974.59 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) issued a firm fixed-price delivery order valued at $16,974.59 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This delivery order, issued on December 9, 2025, represents one of numerous pharmaceutical supply orders placed with DMS Pharmaceutical Group under the agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. The award carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. Performance will be completed in Park Ridge, Illinois, with an ultimate completion date of December 10, 2025.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the DLA, valued at $499,999,999 and established on November 13, 2025, under the broader $30.3 billion PPV-G GEN V acquisition strategy. The IDC authorizes DLA to procure a comprehensive range of pharmaceutical products including branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, and medical consumables to support Department of Defense military healthcare facilities worldwide. DMS Pharmaceutical Group's established track record on numerous prior delivery orders demonstrates its capability to fulfill the specialized pharmaceutical requirements of the federal military medical system, with no identified subcontractor relationships on this award.
Quick answers
Who was awarded contract SPE2DU26FEMPB?
SPE2DU26FEMPB was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 9, 2025.
How much is contract SPE2DU26FEMPB worth?
The government has obligated $16,975 on SPE2DU26FEMPB.
Is contract SPE2DU26FEMPB an order under another contract?
Yes. SPE2DU26FEMPB is a delivery order under SPE2DU25D9517, an indefinite delivery contract.
Was contract SPE2DU26FEMPB competed?
The extent of competition for SPE2DU26FEMPB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award